SlideShare une entreprise Scribd logo
1  sur  23
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Table (1-A):   Patient’s distribution by clinicians and  clinical possibility (n.870)‏ ** P < 0.001 100.0 870 (100%)‏ 100.0 398 (45.7%)‏ 99.9 180 (20.7%)‏ 100.0 292 (33.6%)‏ Total  86.2** 13.8** 750 120 77.9** 22.1** 310 88 87.7** 12.2** 158 22 96.6** 3.4** 282 10 Correct ???? %  No. %  No. %  No. %  No. Total  G.Ps Other specialities Chest speciality Item
[object Object],Table (1-B):  Geographical distribution 100.0 750 Total Item 38.8* 34.5* 24.5** 2.2** 291 259 184 16 Cairo Lower Egypt Upper Egypt Peripheral % No.
Table (2):  Ventilatory functions (n.750)‏ ** P < 0.001 100.0 750 (99.9%)‏ 100 310 (41.3%)‏ 9.9 158 (21.0%)‏ 99.9 282 (37.6%)‏ Total  10.8** 89.2** 81 669 0 100 0 310 12.0** 87.9** 19 139 21.9** 78.0** 62 220 Done Not done %  No. %  No. %  No. %  No. Total  G.Ps Other specialities Chest speciality Item
Table (3):  Diagnosis and classification according to  GINA guidelines (n.750)‏ ** P < 0.001 99.9 750 (99.9%)‏ 100 310 (41.3%)‏ 100.0 158 (21.0%)‏ 100.0 282 (37.6%)‏ Total  8.5** 91.4** 64 686 0 100 0 310 10.8** 89.2** 16 142 17.0** 83.0** 48 234 Possible  Not possible  %  No. %  No. %  No. %  No. Total  G.Ps Other specialities Chest speciality Item
Table (4):  Compliance in management according to  GINA guidelines (n.750)‏ ** P < 0.001 99.9 750 (99.9%)‏ 100 310 (41.3%)‏ 100.0 158 (21.0%)‏ 100.0 282 (37.6%)‏ Total  6.9** 93.0** 52 698 0 100 0 310 7.5** 92.4 12 146 14.2** 85.8** 40 242 Complying Not complying %  No. %  No. %  No. %  No. Total  G.Ps Other specialities Chest speciality Item
Table (5):  Compliance in management according to  Egyptian guidelines (n. 750)‏ ** P < 0.001 99.9 750 (99.9%)‏ 100 310 (41.3%)‏ 100.0 158 (21.0%)‏ 100.0 282 (37.6%)‏ Total  6.9** 93.0** 52 698 0 180 0 310 7.6** 92.4 12 146 14.2** 85.8** 40 242 Complying Not complying %  No. %  No. %  No. %  No. Total  G.Ps Other specialities Chest speciality Item
Table (6):  Main items of non-compliance (n.698)‏ * P < 0.05  ** P < 0.001 100.0 698 (100%)‏ 100.0 310 (44.4%)‏ 100.0 146 (20.9%)‏ 99.9 242 (34.7%)‏ Total 40.2* 34.8* 25.0** 281 243 174 30.3 25.8 43.9** 94 80 136 51.4 41.1 - 7.5** 75 60 11 46.3 42.5 11.1** 112 103 27 Inhalation therapy Corticoid therapy Both  %  No. %  No. %  No. %  No. Total  G.Ps Other specialities Chest speciality Item
Table (7):  Duration of treatment by clinicians (n.750)‏ ** P < 0.001 between patients managed by chest specialists and  other patients, who also showed the same difference when less and  more than three months duration were compared. 49.2** 50.7** 87.3** 12.7^^ 90.0** 10.0** 74.0** 25.9** 99.9 750 100.0 310 100.0 158 99.9 282 Total 36.8 14.6 22.6 5.5 20.4 276 110 170 41 153 76.8 7.1 6.1 5.2 4.8 238 22 19 16 15 13.9 19.6 53.8 7.6 5.1 22 31 85 12 78 5.6 20.23 23.4 4.6 46.1 16 57 66 13 130 < 1 month 1 - < 2 month 2 - < 3 month 3 - < 4 month 4 or more months %  No. %  No. %  No. %  No. Total  G.Ps Other specialities Chest speciality Item
Table (8):  Cause of non-compliance (n. 906)#. # More than one cause may be encountered in one patient. ** P < 0.001 99.9 906 (100%)‏ 100.0 34.4 (38.4%)‏ 99.8 221 (24.4%)‏ 99.9 337 (37.2%)‏ Total # 31.0 26.8 19.2 19.1 3.8 281 243 174 173 35 27.6 22.9 38.6** 6.3** 4.6 94 80 136 22 16 33.9 27.1 4.9** 30.3** 3.6 75 60 11 67 8 33.2 30.5 8.0** 24.9** 3.3 112 103 27 84 11 Inhalation phobia Corticoid phobia Both Cost Others  %  No. %  No. %  No. %  No. Total  G.Ps Other specialities Chest speciality Item
Table (9):  Analysis of inhalation non-compliance (n.436)# # More than one cause may be encountered in one patient. ** P < 0.001 99.8 436 (99.9%)‏ 99.8 116 (26.6%)‏ 99.8 195 (30.9%)‏ 100.0 185 (42.4%)‏ Total # 33.2** 11.0** 15.8** 39.6** 145 49 69: 44 25 173 64.6** 12.9** 3.4** 18.9** 75 15 4: 2 2 22 22.9** 8.8** 18.5** 49.6** 31 12 25: 16 9 67 21.1** 11.9** 21.6** 45.4** 39 22 40: 26 14 84 Corticoid  inhalation Non-corticoid inhalation Both: One vehicle > One vehicle Cost  %  No. %  No. %  No. %  No. Total  G.Ps Other specialities Chest speciality Item
Table (10):  Analysis of corticoid non-compliance (n.395)# # More than one cause may be encountered in one patient. ** P < 0.001 99.9 395 (100%)‏ 100.0 94 (23.8%)‏ 99.8 126 (30.4%)‏ 99.9 181 (45.8%)‏ Total # 25.8 21.5 8.8** 43.8** 102 85 35: 22 13 173 36.2** 23.4** 17.0** 23.4** 34 22 16: 10 6 2.2 24.1** 13.3** 6.6** 55.8** 29 16 8: 5 3 67 21.5** 25.9** 6.1** 46.4** 39 22 11: 7 4 84 Corticoid  inhalation Non-corticoid inhalation Both: One vehicle > One vehicle Cost  %  No. %  No. %  No. %  No. Total  G.Ps Other specialities Chest speciality Item
[object Object],[object Object],[object Object],Table (11):  Management outcome (n.1160)‏ 99.9 1160 (99.9%)‏ 99.9 358 (30.8%)‏ 100.0 278 (23.9%)‏ 100.0 524 (45.2%)‏ Total # 35.3** 15.5** 49.1** 410 180 570 13.4** 6.1** 80.4** 48 22 288 43.2** 14.7** 42.1** 120 41 117 46.2** 22.3** 31.5** 242 117 165 Releif # Control # Failure %  No. %  No. %  No. %  No. Total  G.Ps Other specialities Chest speciality Item
Table (12):  Responsibility of management failure (n.570)‏ ** P < 0.001 99.9 570 (99.9%)‏ 99.9 288 (50.5%)‏ 99.9 117 (20.5%)‏ 100.0 165 (28.9%)‏ Total # 65.6** 18.4** 15.9 374 105 91 51.7** 22.9** 25.3 14.9 66 73 70.9** 18.8** 10.2 83 22 12 86.1 10.3 3.6 142 17 6 Patient’s factor Physician’s factor Both  %  No. %  No. %  No. %  No. Total  G.Ps Other specialities Chest speciality Item
[object Object],[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object]
[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 

Contenu connexe

Tendances

Barefoot_McGrath_Oliver_Poster_11032014
Barefoot_McGrath_Oliver_Poster_11032014Barefoot_McGrath_Oliver_Poster_11032014
Barefoot_McGrath_Oliver_Poster_11032014Danielle Barefoot
 
How to read a receiver operating characteritic (ROC) curve
How to read a receiver operating characteritic (ROC) curveHow to read a receiver operating characteritic (ROC) curve
How to read a receiver operating characteritic (ROC) curveSamir Haffar
 
Palumbo auto hsct in multiple myeloma n engl j med 2014
Palumbo auto hsct in multiple myeloma n engl j med 2014Palumbo auto hsct in multiple myeloma n engl j med 2014
Palumbo auto hsct in multiple myeloma n engl j med 2014Chandan K Das
 
MCO 2011 - Slide 26 - C. Faivre-Finn - Radiotherapy
MCO 2011 - Slide 26 - C. Faivre-Finn - RadiotherapyMCO 2011 - Slide 26 - C. Faivre-Finn - Radiotherapy
MCO 2011 - Slide 26 - C. Faivre-Finn - RadiotherapyEuropean School of Oncology
 
Treating Human Cancers with Medicinal Mushroom Preparations (Croatian Experie...
Treating Human Cancers with Medicinal Mushroom Preparations (Croatian Experie...Treating Human Cancers with Medicinal Mushroom Preparations (Croatian Experie...
Treating Human Cancers with Medicinal Mushroom Preparations (Croatian Experie...Neven Jakopovic
 
Medicinal Mushroom Preparations against Lung Cancer
Medicinal Mushroom Preparations against Lung CancerMedicinal Mushroom Preparations against Lung Cancer
Medicinal Mushroom Preparations against Lung CancerNeven Jakopovic
 
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...inventionjournals
 
Club de revistas anestesia pediátrica
Club de revistas anestesia pediátrica Club de revistas anestesia pediátrica
Club de revistas anestesia pediátrica Socundianeste
 
Dermatoglyphics in pulmonary tuberculosis
Dermatoglyphics in pulmonary tuberculosisDermatoglyphics in pulmonary tuberculosis
Dermatoglyphics in pulmonary tuberculosisCA. Sanjay Ruia
 
Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...
Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...
Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...Marmara University School of Medicine
 
Cost and Time Effectiveness of Hypohthermia Guidelines in an Adult Outpatient...
Cost and Time Effectiveness of Hypohthermia Guidelines in an Adult Outpatient...Cost and Time Effectiveness of Hypohthermia Guidelines in an Adult Outpatient...
Cost and Time Effectiveness of Hypohthermia Guidelines in an Adult Outpatient...Devon Berry
 
Journal club presentation @ Rxvichu!!
Journal club presentation @ Rxvichu!!Journal club presentation @ Rxvichu!!
Journal club presentation @ Rxvichu!!RxVichuZ
 
Alzheimer's Disease-NMA- capt 2016 -poster presentation
Alzheimer's Disease-NMA- capt 2016 -poster presentationAlzheimer's Disease-NMA- capt 2016 -poster presentation
Alzheimer's Disease-NMA- capt 2016 -poster presentationNaghmeh Foroutan
 
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...Mina Max
 
The Effect of Vancomycin Doses Greater Than 2 Grams on Serum
The Effect of Vancomycin Doses Greater Than 2 Grams on SerumThe Effect of Vancomycin Doses Greater Than 2 Grams on Serum
The Effect of Vancomycin Doses Greater Than 2 Grams on SerumJordan Mustonen
 
Methodology Atlas nº6. Atlas of variations in oncologic surgery hopitalisations
Methodology Atlas nº6. Atlas of variations in oncologic surgery hopitalisationsMethodology Atlas nº6. Atlas of variations in oncologic surgery hopitalisations
Methodology Atlas nº6. Atlas of variations in oncologic surgery hopitalisationsAtlas VPM
 

Tendances (20)

Barefoot_McGrath_Oliver_Poster_11032014
Barefoot_McGrath_Oliver_Poster_11032014Barefoot_McGrath_Oliver_Poster_11032014
Barefoot_McGrath_Oliver_Poster_11032014
 
Hodgkins disease trial 11
Hodgkins disease trial 11Hodgkins disease trial 11
Hodgkins disease trial 11
 
How to read a receiver operating characteritic (ROC) curve
How to read a receiver operating characteritic (ROC) curveHow to read a receiver operating characteritic (ROC) curve
How to read a receiver operating characteritic (ROC) curve
 
Metanlysis adjuvant pancreatic
Metanlysis adjuvant pancreaticMetanlysis adjuvant pancreatic
Metanlysis adjuvant pancreatic
 
Palumbo auto hsct in multiple myeloma n engl j med 2014
Palumbo auto hsct in multiple myeloma n engl j med 2014Palumbo auto hsct in multiple myeloma n engl j med 2014
Palumbo auto hsct in multiple myeloma n engl j med 2014
 
MCO 2011 - Slide 26 - C. Faivre-Finn - Radiotherapy
MCO 2011 - Slide 26 - C. Faivre-Finn - RadiotherapyMCO 2011 - Slide 26 - C. Faivre-Finn - Radiotherapy
MCO 2011 - Slide 26 - C. Faivre-Finn - Radiotherapy
 
Treating Human Cancers with Medicinal Mushroom Preparations (Croatian Experie...
Treating Human Cancers with Medicinal Mushroom Preparations (Croatian Experie...Treating Human Cancers with Medicinal Mushroom Preparations (Croatian Experie...
Treating Human Cancers with Medicinal Mushroom Preparations (Croatian Experie...
 
Medicinal Mushroom Preparations against Lung Cancer
Medicinal Mushroom Preparations against Lung CancerMedicinal Mushroom Preparations against Lung Cancer
Medicinal Mushroom Preparations against Lung Cancer
 
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
 
Club de revistas anestesia pediátrica
Club de revistas anestesia pediátrica Club de revistas anestesia pediátrica
Club de revistas anestesia pediátrica
 
Dermatoglyphics in pulmonary tuberculosis
Dermatoglyphics in pulmonary tuberculosisDermatoglyphics in pulmonary tuberculosis
Dermatoglyphics in pulmonary tuberculosis
 
Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...
Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...
Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...
 
Cost and Time Effectiveness of Hypohthermia Guidelines in an Adult Outpatient...
Cost and Time Effectiveness of Hypohthermia Guidelines in an Adult Outpatient...Cost and Time Effectiveness of Hypohthermia Guidelines in an Adult Outpatient...
Cost and Time Effectiveness of Hypohthermia Guidelines in an Adult Outpatient...
 
Journal club presentation @ Rxvichu!!
Journal club presentation @ Rxvichu!!Journal club presentation @ Rxvichu!!
Journal club presentation @ Rxvichu!!
 
Alzheimer's Disease-NMA- capt 2016 -poster presentation
Alzheimer's Disease-NMA- capt 2016 -poster presentationAlzheimer's Disease-NMA- capt 2016 -poster presentation
Alzheimer's Disease-NMA- capt 2016 -poster presentation
 
NET - Kennecke
NET - KenneckeNET - Kennecke
NET - Kennecke
 
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
 
The Effect of Vancomycin Doses Greater Than 2 Grams on Serum
The Effect of Vancomycin Doses Greater Than 2 Grams on SerumThe Effect of Vancomycin Doses Greater Than 2 Grams on Serum
The Effect of Vancomycin Doses Greater Than 2 Grams on Serum
 
Methodology Atlas nº6. Atlas of variations in oncologic surgery hopitalisations
Methodology Atlas nº6. Atlas of variations in oncologic surgery hopitalisationsMethodology Atlas nº6. Atlas of variations in oncologic surgery hopitalisations
Methodology Atlas nº6. Atlas of variations in oncologic surgery hopitalisations
 
Superficial bladder cancer
Superficial bladder cancerSuperficial bladder cancer
Superficial bladder cancer
 

En vedette

Approach to Chronic wheezing & asthma an update 2013
Approach to Chronic wheezing & asthma an update 2013Approach to Chronic wheezing & asthma an update 2013
Approach to Chronic wheezing & asthma an update 2013avicena1
 
Engaging patients with social media
Engaging patients with social mediaEngaging patients with social media
Engaging patients with social mediaTao Le
 
Teaching with Technology in Medical Education
Teaching with Technology in Medical EducationTeaching with Technology in Medical Education
Teaching with Technology in Medical EducationTao Le
 
Homemade Remedies for Asthma - 039
Homemade Remedies for Asthma - 039Homemade Remedies for Asthma - 039
Homemade Remedies for Asthma - 039sinfome.com
 
Preschool wheezy children
Preschool wheezy childrenPreschool wheezy children
Preschool wheezy childrenGamal Agmy
 
Interactive Bees: Website Design and Development Company Portfolio Delhi India
Interactive Bees: Website Design and Development Company Portfolio Delhi IndiaInteractive Bees: Website Design and Development Company Portfolio Delhi India
Interactive Bees: Website Design and Development Company Portfolio Delhi IndiaInteractive Bees
 
Dd wheezy chest in infant for fm
Dd wheezy chest in infant for fmDd wheezy chest in infant for fm
Dd wheezy chest in infant for fmHussein Abdeldayem
 
Wheezy chest in pediatrics
Wheezy chest in pediatrics Wheezy chest in pediatrics
Wheezy chest in pediatrics danielrawand
 
Wheeze in Children
Wheeze in ChildrenWheeze in Children
Wheeze in Childrendivyaanair
 

En vedette (9)

Approach to Chronic wheezing & asthma an update 2013
Approach to Chronic wheezing & asthma an update 2013Approach to Chronic wheezing & asthma an update 2013
Approach to Chronic wheezing & asthma an update 2013
 
Engaging patients with social media
Engaging patients with social mediaEngaging patients with social media
Engaging patients with social media
 
Teaching with Technology in Medical Education
Teaching with Technology in Medical EducationTeaching with Technology in Medical Education
Teaching with Technology in Medical Education
 
Homemade Remedies for Asthma - 039
Homemade Remedies for Asthma - 039Homemade Remedies for Asthma - 039
Homemade Remedies for Asthma - 039
 
Preschool wheezy children
Preschool wheezy childrenPreschool wheezy children
Preschool wheezy children
 
Interactive Bees: Website Design and Development Company Portfolio Delhi India
Interactive Bees: Website Design and Development Company Portfolio Delhi IndiaInteractive Bees: Website Design and Development Company Portfolio Delhi India
Interactive Bees: Website Design and Development Company Portfolio Delhi India
 
Dd wheezy chest in infant for fm
Dd wheezy chest in infant for fmDd wheezy chest in infant for fm
Dd wheezy chest in infant for fm
 
Wheezy chest in pediatrics
Wheezy chest in pediatrics Wheezy chest in pediatrics
Wheezy chest in pediatrics
 
Wheeze in Children
Wheeze in ChildrenWheeze in Children
Wheeze in Children
 

Similaire à Defects in Asthma Management

MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)European School of Oncology
 
MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)European School of Oncology
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...JohnJulie1
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...AnonIshanvi
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...EditorSara
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...NainaAnon
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...daranisaha
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...semualkaira
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...semualkaira
 
BALKAN MCO 2011 - A. Cervantes - Systemic treatment of advanced disease
BALKAN MCO 2011 - A. Cervantes - Systemic treatment of advanced disease BALKAN MCO 2011 - A. Cervantes - Systemic treatment of advanced disease
BALKAN MCO 2011 - A. Cervantes - Systemic treatment of advanced disease European School of Oncology
 
MON 2011 - Slide 23 - C. Faivre-Finn - Radiotherapy
MON 2011 - Slide 23 - C. Faivre-Finn - RadiotherapyMON 2011 - Slide 23 - C. Faivre-Finn - Radiotherapy
MON 2011 - Slide 23 - C. Faivre-Finn - RadiotherapyEuropean School of Oncology
 
Cáncer páncreas 2017
Cáncer páncreas 2017Cáncer páncreas 2017
Cáncer páncreas 2017UACH, Valdivia
 
Reasons for discontinuing allergen subcutaneous immunotherapy
Reasons for discontinuing allergen subcutaneous immunotherapyReasons for discontinuing allergen subcutaneous immunotherapy
Reasons for discontinuing allergen subcutaneous immunotherapyNatacha Santos
 
Packer Stop Af1
Packer Stop Af1Packer Stop Af1
Packer Stop Af1enforme
 
Role of systemic therapy in management of laryngeal carcinoma
Role of systemic therapy in management of laryngeal carcinomaRole of systemic therapy in management of laryngeal carcinoma
Role of systemic therapy in management of laryngeal carcinomaMohammed Fathy
 
Kshivets O. Lung Cancer Stage III Surgery
Kshivets O. Lung Cancer Stage III Surgery Kshivets O. Lung Cancer Stage III Surgery
Kshivets O. Lung Cancer Stage III Surgery Oleg Kshivets
 
Early Stage Nsclc The Role Of Chemotherapy
Early Stage Nsclc The Role Of ChemotherapyEarly Stage Nsclc The Role Of Chemotherapy
Early Stage Nsclc The Role Of Chemotherapyfondas vakalis
 
Evolution of mechanical ventilation in the last 20 years
Evolution of mechanical ventilation in the last 20 yearsEvolution of mechanical ventilation in the last 20 years
Evolution of mechanical ventilation in the last 20 yearsDr.Mahmoud Abbas
 

Similaire à Defects in Asthma Management (20)

MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MCO 2011 - Slide 21 - P. Rougier - Adjuvant treatment (stage 2 and 3)
 
MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)
MON 2011 - Slide 19 - P. Rougier - Adjuvant treatment (stage 2 and 3)
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
 
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alt...
 
BALKAN MCO 2011 - A. Cervantes - Systemic treatment of advanced disease
BALKAN MCO 2011 - A. Cervantes - Systemic treatment of advanced disease BALKAN MCO 2011 - A. Cervantes - Systemic treatment of advanced disease
BALKAN MCO 2011 - A. Cervantes - Systemic treatment of advanced disease
 
MON 2011 - Slide 23 - C. Faivre-Finn - Radiotherapy
MON 2011 - Slide 23 - C. Faivre-Finn - RadiotherapyMON 2011 - Slide 23 - C. Faivre-Finn - Radiotherapy
MON 2011 - Slide 23 - C. Faivre-Finn - Radiotherapy
 
Cáncer páncreas 2017
Cáncer páncreas 2017Cáncer páncreas 2017
Cáncer páncreas 2017
 
Reasons for discontinuing allergen subcutaneous immunotherapy
Reasons for discontinuing allergen subcutaneous immunotherapyReasons for discontinuing allergen subcutaneous immunotherapy
Reasons for discontinuing allergen subcutaneous immunotherapy
 
1 Hassan
1  Hassan1  Hassan
1 Hassan
 
Packer Stop Af1
Packer Stop Af1Packer Stop Af1
Packer Stop Af1
 
Role of systemic therapy in management of laryngeal carcinoma
Role of systemic therapy in management of laryngeal carcinomaRole of systemic therapy in management of laryngeal carcinoma
Role of systemic therapy in management of laryngeal carcinoma
 
Kshivets O. Lung Cancer Stage III Surgery
Kshivets O. Lung Cancer Stage III Surgery Kshivets O. Lung Cancer Stage III Surgery
Kshivets O. Lung Cancer Stage III Surgery
 
Update from CROI 2018: Focus on TB and Other Opportunistic Infections
Update from CROI 2018: Focus on TB and Other Opportunistic InfectionsUpdate from CROI 2018: Focus on TB and Other Opportunistic Infections
Update from CROI 2018: Focus on TB and Other Opportunistic Infections
 
Early Stage Nsclc The Role Of Chemotherapy
Early Stage Nsclc The Role Of ChemotherapyEarly Stage Nsclc The Role Of Chemotherapy
Early Stage Nsclc The Role Of Chemotherapy
 
Evolution of mechanical ventilation in the last 20 years
Evolution of mechanical ventilation in the last 20 yearsEvolution of mechanical ventilation in the last 20 years
Evolution of mechanical ventilation in the last 20 years
 

Dernier

05_Annelore Lenoir_Docbyte_MeetupDora&Cybersecurity.pptx
05_Annelore Lenoir_Docbyte_MeetupDora&Cybersecurity.pptx05_Annelore Lenoir_Docbyte_MeetupDora&Cybersecurity.pptx
05_Annelore Lenoir_Docbyte_MeetupDora&Cybersecurity.pptxFinTech Belgium
 
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service NashikHigh Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service NashikCall Girls in Nagpur High Profile
 
Stock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdfStock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdfMichael Silva
 
The Economic History of the U.S. Lecture 19.pdf
The Economic History of the U.S. Lecture 19.pdfThe Economic History of the U.S. Lecture 19.pdf
The Economic History of the U.S. Lecture 19.pdfGale Pooley
 
Vip Call US 📞 7738631006 ✅Call Girls In Sakinaka ( Mumbai )
Vip Call US 📞 7738631006 ✅Call Girls In Sakinaka ( Mumbai )Vip Call US 📞 7738631006 ✅Call Girls In Sakinaka ( Mumbai )
Vip Call US 📞 7738631006 ✅Call Girls In Sakinaka ( Mumbai )Pooja Nehwal
 
The Economic History of the U.S. Lecture 26.pdf
The Economic History of the U.S. Lecture 26.pdfThe Economic History of the U.S. Lecture 26.pdf
The Economic History of the U.S. Lecture 26.pdfGale Pooley
 
The Economic History of the U.S. Lecture 25.pdf
The Economic History of the U.S. Lecture 25.pdfThe Economic History of the U.S. Lecture 25.pdf
The Economic History of the U.S. Lecture 25.pdfGale Pooley
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escortsranjana rawat
 
Gurley shaw Theory of Monetary Economics.
Gurley shaw Theory of Monetary Economics.Gurley shaw Theory of Monetary Economics.
Gurley shaw Theory of Monetary Economics.Vinodha Devi
 
Booking open Available Pune Call Girls Shivane 6297143586 Call Hot Indian Gi...
Booking open Available Pune Call Girls Shivane  6297143586 Call Hot Indian Gi...Booking open Available Pune Call Girls Shivane  6297143586 Call Hot Indian Gi...
Booking open Available Pune Call Girls Shivane 6297143586 Call Hot Indian Gi...Call Girls in Nagpur High Profile
 
The Economic History of the U.S. Lecture 21.pdf
The Economic History of the U.S. Lecture 21.pdfThe Economic History of the U.S. Lecture 21.pdf
The Economic History of the U.S. Lecture 21.pdfGale Pooley
 
Top Rated Pune Call Girls Viman Nagar ⟟ 6297143586 ⟟ Call Me For Genuine Sex...
Top Rated  Pune Call Girls Viman Nagar ⟟ 6297143586 ⟟ Call Me For Genuine Sex...Top Rated  Pune Call Girls Viman Nagar ⟟ 6297143586 ⟟ Call Me For Genuine Sex...
Top Rated Pune Call Girls Viman Nagar ⟟ 6297143586 ⟟ Call Me For Genuine Sex...Call Girls in Nagpur High Profile
 
Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...
Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...
Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...Pooja Nehwal
 
Booking open Available Pune Call Girls Wadgaon Sheri 6297143586 Call Hot Ind...
Booking open Available Pune Call Girls Wadgaon Sheri  6297143586 Call Hot Ind...Booking open Available Pune Call Girls Wadgaon Sheri  6297143586 Call Hot Ind...
Booking open Available Pune Call Girls Wadgaon Sheri 6297143586 Call Hot Ind...Call Girls in Nagpur High Profile
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignHenry Tapper
 

Dernier (20)

05_Annelore Lenoir_Docbyte_MeetupDora&Cybersecurity.pptx
05_Annelore Lenoir_Docbyte_MeetupDora&Cybersecurity.pptx05_Annelore Lenoir_Docbyte_MeetupDora&Cybersecurity.pptx
05_Annelore Lenoir_Docbyte_MeetupDora&Cybersecurity.pptx
 
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service NashikHigh Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
 
Stock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdfStock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdf
 
The Economic History of the U.S. Lecture 19.pdf
The Economic History of the U.S. Lecture 19.pdfThe Economic History of the U.S. Lecture 19.pdf
The Economic History of the U.S. Lecture 19.pdf
 
Vip Call US 📞 7738631006 ✅Call Girls In Sakinaka ( Mumbai )
Vip Call US 📞 7738631006 ✅Call Girls In Sakinaka ( Mumbai )Vip Call US 📞 7738631006 ✅Call Girls In Sakinaka ( Mumbai )
Vip Call US 📞 7738631006 ✅Call Girls In Sakinaka ( Mumbai )
 
The Economic History of the U.S. Lecture 26.pdf
The Economic History of the U.S. Lecture 26.pdfThe Economic History of the U.S. Lecture 26.pdf
The Economic History of the U.S. Lecture 26.pdf
 
The Economic History of the U.S. Lecture 25.pdf
The Economic History of the U.S. Lecture 25.pdfThe Economic History of the U.S. Lecture 25.pdf
The Economic History of the U.S. Lecture 25.pdf
 
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
 
Gurley shaw Theory of Monetary Economics.
Gurley shaw Theory of Monetary Economics.Gurley shaw Theory of Monetary Economics.
Gurley shaw Theory of Monetary Economics.
 
(INDIRA) Call Girl Mumbai Call Now 8250077686 Mumbai Escorts 24x7
(INDIRA) Call Girl Mumbai Call Now 8250077686 Mumbai Escorts 24x7(INDIRA) Call Girl Mumbai Call Now 8250077686 Mumbai Escorts 24x7
(INDIRA) Call Girl Mumbai Call Now 8250077686 Mumbai Escorts 24x7
 
Booking open Available Pune Call Girls Shivane 6297143586 Call Hot Indian Gi...
Booking open Available Pune Call Girls Shivane  6297143586 Call Hot Indian Gi...Booking open Available Pune Call Girls Shivane  6297143586 Call Hot Indian Gi...
Booking open Available Pune Call Girls Shivane 6297143586 Call Hot Indian Gi...
 
The Economic History of the U.S. Lecture 21.pdf
The Economic History of the U.S. Lecture 21.pdfThe Economic History of the U.S. Lecture 21.pdf
The Economic History of the U.S. Lecture 21.pdf
 
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
 
VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
 
(Vedika) Low Rate Call Girls in Pune Call Now 8250077686 Pune Escorts 24x7
(Vedika) Low Rate Call Girls in Pune Call Now 8250077686 Pune Escorts 24x7(Vedika) Low Rate Call Girls in Pune Call Now 8250077686 Pune Escorts 24x7
(Vedika) Low Rate Call Girls in Pune Call Now 8250077686 Pune Escorts 24x7
 
Top Rated Pune Call Girls Viman Nagar ⟟ 6297143586 ⟟ Call Me For Genuine Sex...
Top Rated  Pune Call Girls Viman Nagar ⟟ 6297143586 ⟟ Call Me For Genuine Sex...Top Rated  Pune Call Girls Viman Nagar ⟟ 6297143586 ⟟ Call Me For Genuine Sex...
Top Rated Pune Call Girls Viman Nagar ⟟ 6297143586 ⟟ Call Me For Genuine Sex...
 
Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...
Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...
Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...
 
Booking open Available Pune Call Girls Wadgaon Sheri 6297143586 Call Hot Ind...
Booking open Available Pune Call Girls Wadgaon Sheri  6297143586 Call Hot Ind...Booking open Available Pune Call Girls Wadgaon Sheri  6297143586 Call Hot Ind...
Booking open Available Pune Call Girls Wadgaon Sheri 6297143586 Call Hot Ind...
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaign
 

Defects in Asthma Management

  • 1.
  • 2.
  • 3. Table (1-A): Patient’s distribution by clinicians and clinical possibility (n.870)‏ ** P < 0.001 100.0 870 (100%)‏ 100.0 398 (45.7%)‏ 99.9 180 (20.7%)‏ 100.0 292 (33.6%)‏ Total 86.2** 13.8** 750 120 77.9** 22.1** 310 88 87.7** 12.2** 158 22 96.6** 3.4** 282 10 Correct ???? %  No. %  No. %  No. %  No. Total G.Ps Other specialities Chest speciality Item
  • 4.
  • 5. Table (2): Ventilatory functions (n.750)‏ ** P < 0.001 100.0 750 (99.9%)‏ 100 310 (41.3%)‏ 9.9 158 (21.0%)‏ 99.9 282 (37.6%)‏ Total 10.8** 89.2** 81 669 0 100 0 310 12.0** 87.9** 19 139 21.9** 78.0** 62 220 Done Not done %  No. %  No. %  No. %  No. Total G.Ps Other specialities Chest speciality Item
  • 6. Table (3): Diagnosis and classification according to GINA guidelines (n.750)‏ ** P < 0.001 99.9 750 (99.9%)‏ 100 310 (41.3%)‏ 100.0 158 (21.0%)‏ 100.0 282 (37.6%)‏ Total 8.5** 91.4** 64 686 0 100 0 310 10.8** 89.2** 16 142 17.0** 83.0** 48 234 Possible Not possible %  No. %  No. %  No. %  No. Total G.Ps Other specialities Chest speciality Item
  • 7. Table (4): Compliance in management according to GINA guidelines (n.750)‏ ** P < 0.001 99.9 750 (99.9%)‏ 100 310 (41.3%)‏ 100.0 158 (21.0%)‏ 100.0 282 (37.6%)‏ Total 6.9** 93.0** 52 698 0 100 0 310 7.5** 92.4 12 146 14.2** 85.8** 40 242 Complying Not complying %  No. %  No. %  No. %  No. Total G.Ps Other specialities Chest speciality Item
  • 8. Table (5): Compliance in management according to Egyptian guidelines (n. 750)‏ ** P < 0.001 99.9 750 (99.9%)‏ 100 310 (41.3%)‏ 100.0 158 (21.0%)‏ 100.0 282 (37.6%)‏ Total 6.9** 93.0** 52 698 0 180 0 310 7.6** 92.4 12 146 14.2** 85.8** 40 242 Complying Not complying %  No. %  No. %  No. %  No. Total G.Ps Other specialities Chest speciality Item
  • 9. Table (6): Main items of non-compliance (n.698)‏ * P < 0.05 ** P < 0.001 100.0 698 (100%)‏ 100.0 310 (44.4%)‏ 100.0 146 (20.9%)‏ 99.9 242 (34.7%)‏ Total 40.2* 34.8* 25.0** 281 243 174 30.3 25.8 43.9** 94 80 136 51.4 41.1 - 7.5** 75 60 11 46.3 42.5 11.1** 112 103 27 Inhalation therapy Corticoid therapy Both %  No. %  No. %  No. %  No. Total G.Ps Other specialities Chest speciality Item
  • 10. Table (7): Duration of treatment by clinicians (n.750)‏ ** P < 0.001 between patients managed by chest specialists and other patients, who also showed the same difference when less and more than three months duration were compared. 49.2** 50.7** 87.3** 12.7^^ 90.0** 10.0** 74.0** 25.9** 99.9 750 100.0 310 100.0 158 99.9 282 Total 36.8 14.6 22.6 5.5 20.4 276 110 170 41 153 76.8 7.1 6.1 5.2 4.8 238 22 19 16 15 13.9 19.6 53.8 7.6 5.1 22 31 85 12 78 5.6 20.23 23.4 4.6 46.1 16 57 66 13 130 < 1 month 1 - < 2 month 2 - < 3 month 3 - < 4 month 4 or more months %  No. %  No. %  No. %  No. Total G.Ps Other specialities Chest speciality Item
  • 11. Table (8): Cause of non-compliance (n. 906)#. # More than one cause may be encountered in one patient. ** P < 0.001 99.9 906 (100%)‏ 100.0 34.4 (38.4%)‏ 99.8 221 (24.4%)‏ 99.9 337 (37.2%)‏ Total # 31.0 26.8 19.2 19.1 3.8 281 243 174 173 35 27.6 22.9 38.6** 6.3** 4.6 94 80 136 22 16 33.9 27.1 4.9** 30.3** 3.6 75 60 11 67 8 33.2 30.5 8.0** 24.9** 3.3 112 103 27 84 11 Inhalation phobia Corticoid phobia Both Cost Others %  No. %  No. %  No. %  No. Total G.Ps Other specialities Chest speciality Item
  • 12. Table (9): Analysis of inhalation non-compliance (n.436)# # More than one cause may be encountered in one patient. ** P < 0.001 99.8 436 (99.9%)‏ 99.8 116 (26.6%)‏ 99.8 195 (30.9%)‏ 100.0 185 (42.4%)‏ Total # 33.2** 11.0** 15.8** 39.6** 145 49 69: 44 25 173 64.6** 12.9** 3.4** 18.9** 75 15 4: 2 2 22 22.9** 8.8** 18.5** 49.6** 31 12 25: 16 9 67 21.1** 11.9** 21.6** 45.4** 39 22 40: 26 14 84 Corticoid inhalation Non-corticoid inhalation Both: One vehicle > One vehicle Cost %  No. %  No. %  No. %  No. Total G.Ps Other specialities Chest speciality Item
  • 13. Table (10): Analysis of corticoid non-compliance (n.395)# # More than one cause may be encountered in one patient. ** P < 0.001 99.9 395 (100%)‏ 100.0 94 (23.8%)‏ 99.8 126 (30.4%)‏ 99.9 181 (45.8%)‏ Total # 25.8 21.5 8.8** 43.8** 102 85 35: 22 13 173 36.2** 23.4** 17.0** 23.4** 34 22 16: 10 6 2.2 24.1** 13.3** 6.6** 55.8** 29 16 8: 5 3 67 21.5** 25.9** 6.1** 46.4** 39 22 11: 7 4 84 Corticoid inhalation Non-corticoid inhalation Both: One vehicle > One vehicle Cost %  No. %  No. %  No. %  No. Total G.Ps Other specialities Chest speciality Item
  • 14.
  • 15. Table (12): Responsibility of management failure (n.570)‏ ** P < 0.001 99.9 570 (99.9%)‏ 99.9 288 (50.5%)‏ 99.9 117 (20.5%)‏ 100.0 165 (28.9%)‏ Total # 65.6** 18.4** 15.9 374 105 91 51.7** 22.9** 25.3 14.9 66 73 70.9** 18.8** 10.2 83 22 12 86.1 10.3 3.6 142 17 6 Patient’s factor Physician’s factor Both %  No. %  No. %  No. %  No. Total G.Ps Other specialities Chest speciality Item
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.